David A. Price - Concepedia

Author

David A. Price

Royal Manchester Children's Hospital ORCID

Also Known As

Arleen Pinkos, Bao S, D A Price, D Price, D. A. PRICE, D. A. Price, D. Price, D.A Price, D.A. PRICE, D.A. Price

138

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

Royal Manchester Children's Hospital Dexcom (United States)University Children's Hospital Tübingen Jaeb Center for Health Research Pfizer (Sweden)

About

David A. Price is an author at Royal Manchester Children's Hospital specializing in medicine, endocrinology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.5K
2	Education	9	9	629
3	Health Sciences	4	4	138
4	Natural Sciences	3	3	211
5	Engineering	1	1	10

David A. Price

Publications

Citations

H-Index

Page 1

	Year	Citations
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections Roy W. Beck, Tonya D. Riddlesworth, Katrina J. Ruedy, JAMA	2017	1.1K
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections Roy W. Beck, Tonya D. Riddlesworth, Katrina J. Ruedy, Annals of Internal Medicine	2017	590
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin Thomas W. Martens, Roy W. Beck, Ryan Bailey, JAMA	2021	445
Derivation and Validation of a Mathematical Model for Predicting the Response to Exogenous Recombinant Human Growth Hormone (GH) in Prepubertal Children with Idiopathic GH Deficiency Michael B. Ranke, Anders Lindberg, Pierre Chatelain, The Journal of Clinical Endocrinology & Metabolism FertilityShort StatureHuman GrowthGynecologyEducation	1999	274
WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease David A. Price, Alex Martinez, Alexandre Seillier, European Journal of Neuroscience	2009	235
Effect of Growth Hormone (GH) Treatment on the Near-Final Height of 1258 Patients with Idiopathic GH Deficiency: Analysis of a Large International Database Edward O. Reiter, David A. Price, Patrick Wilton, The Journal of Clinical Endocrinology & Metabolism	2006	208
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor David A. Griffith, David J. Edmonds, Jean‐Philippe Fortin, Journal of Medicinal Chemistry Insulin SignalingGastrointestinal Peptide HormoneMolecular PharmacologyInsulin DeliveryMolecular Physiology	2022	140
Biochemical Tests in the Diagnosis of Childhood Growth Hormone Deficiency* Vallo Tillmann, John Buckler, Mohammed Kibirige, The Journal of Clinical Endocrinology & Metabolism Gh DeficiencyPituitary GlandGrowth HormoneGh TestHuman Growth	1997	138
A New-Generation Continuous Glucose Monitoring System: Improved Accuracy and Reliability Compared with a Previous-Generation System Mark P. Christiansen, Timothy S. Bailey, Elaine Watkins, Diabetes Technology & Therapeutics	2013	132
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma Pat Kendall‐Taylor, Peter Jönsson, Roger Abs, European Journal of Endocrinology	2005	126

Page 1